Your browser doesn't support javascript.
loading
Tear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females.
Fineide, Fredrik A; Tashbayev, Behzod; Elgstøen, Katja B P; Sandås, Elise M; Rootwelt, Helge; Hynne, Håvard; Chen, Xiangjun; Ræder, Sten; Vehof, Jelle; Dartt, Darlene; Jensen, Janicke L; Utheim, Tor P.
Afiliación
  • Fineide FA; The Norwegian Dry Eye Clinic, 0366 Oslo, Norway.
  • Tashbayev B; Department of Medical Biochemistry, Oslo University Hospital, 0450 Oslo, Norway.
  • Elgstøen KBP; Department of Computer Science, Oslo Metropolitan University, 0130 Oslo, Norway.
  • Sandås EM; The Norwegian Dry Eye Clinic, 0366 Oslo, Norway.
  • Rootwelt H; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, 0313 Oslo, Norway.
  • Hynne H; Department of Medical Biochemistry, Oslo University Hospital, 0450 Oslo, Norway.
  • Chen X; Department of Medical Biochemistry, Oslo University Hospital, 0450 Oslo, Norway.
  • Ræder S; Department of Medical Biochemistry, Oslo University Hospital, 0450 Oslo, Norway.
  • Vehof J; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, 0313 Oslo, Norway.
  • Dartt D; Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, 0313 Oslo, Norway.
  • Jensen JL; Department of Ophthalmology, Drammen Hospital Trust, 3004 Drammen, Norway.
  • Utheim TP; Department of Ophthalmology, Sørlandet Hospital Trust, 4838 Arendal, Norway.
Metabolites ; 13(11)2023 Nov 02.
Article en En | MEDLINE | ID: mdl-37999221
Accurate diagnosis of dry eye disease (DED) is challenging, and even today there is no gold standard biomarker of DED. Hypothesis-free global metabolomic studies of tears from DED patients have great potential to discover metabolites and pathways affected in the pathophysiology of DED, and to identify possible future biomarkers. These metabolites and biomarkers could be important for diagnosing and monitoring disease as well as for new therapeutic targets and strategies. As DED is associated with dry mouth, this study aimed to perform metabolomic analyses of tears and saliva from patients with decreased tear film break-up time but normal Schirmer test, and age-matched controls with both tear production and stability within physiological range. We applied strict inclusion criteria to reduce sampling bias in the metabolomic analyses and selected only age-matched females with Schirmer test values between 10-15 mm/5 min. The tear film analysis arm included 19 patients (with tear film break-up time 0-5 s) and 12 controls (with tear film break-up time 10-30 s), while the salivary analysis arm consisted of a subset which included 18 patients and six controls. Metabolomic analyses were performed using liquid chromatography and high-resolution mass spectrometry. Analyses using a global database search detected a total of 56 metabolites in tear samples that were significantly different between the groups. Of these, several have known associations with DED. These metabolites are present in meibum and have anti-oxidative characteristics or associations with the ocular microbiome, and altered concentrations suggest that they may play a significant role in DED associated with decreased tear film stability. In saliva, hypotaurine levels were lower among patients with tear film instability. In this pilot study, we found different levels of several metabolites in patients with decreased tear film break-up time that may have associations with DED. Future studies are required to replicate our findings and clarify the exact roles of these metabolites.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Metabolites Año: 2023 Tipo del documento: Article País de afiliación: Noruega

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Metabolites Año: 2023 Tipo del documento: Article País de afiliación: Noruega